ORBIMED ADVISORS LLC – ORIC Pharmaceuticals, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$6.68M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
-28.57%
quarter
ORIC Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | 0.00% | 0 shares | -2.67M | $3.2 | 2.08M | |
Q2 2022 | share | 0.00% | 0 shares | -1.79M | $4.48 | 2.08M | |
Q1 2022 | share | Decrease | -10.70% | -250.00K shares | -23.21M | $5.34 | 2.08M |
Q4 2021 | share | 0.00% | 0 shares | -14.51M | $15.59 | 2.33M | |
Q3 2021 | share | 0.00% | 0 shares | 7.52M | $20.91 | 2.33M | |
Q2 2021 | share | 0.00% | 0 shares | -15.91M | $17.69 | 2.33M | |
Q1 2021 | share | Decrease | -20.00% | -584.39K shares | -41.63M | $24.5 | 2.33M |
Q4 2020 | share | 0.00% | 0 shares | 25.83M | $33.85 | 2.92M | |
Q3 2020 | share | 0.00% | 0 shares | -25.48M | $25.01 | 2.92M | |
Q2 2020 | share | Increase | 0.00% | 2.92M shares | 98.55M | $33.73 | 2.92M |